|
|
 |
| Professor |
| Office: 919-966-3725 |
| E-mail: john_chapman@med.unc.edu |
| |
| |
| |
| My
current research interests include (1) development and clinical
evaluation of new laboratory tests for fetal lung maturity
(FLM), (2) practical application of analytical methods for
determining multiple health effects of CVD risk factor interventions,
and (3) development and evaluation of new biochemical methods
and instrumentation. |
| |
| |
| Dungan K, Chapman JF, Braithwaite SS and Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007 Feb;30(2):403-9. |
| |
| Parvin
CA, Kaplan LA, Chapman JF, McManamon TG and Gronowski AM.
Predicting respiratory distress syndrome using gestational
age and fetal lung maturity by fluorescent polarization.
Am J Obstet Gynecol 2005; 192:199-207. |
| |
| Snyder JA, Rogers MW, King MS, Phillips JC, Chapman JF and
Hammett-Stabler CA. The Impact of hemolysis on Ortho Clinical
Diagnostic’s ECi and Roche’s Elecsys Immunoassay
systems. Clin Chim Acta 2004; 348: 181-7. |
| |
| Chapman JF, Ashwood ER, Feld FR and Wu AHB. Evaluation
of two-dimensional cytometric lamellar body counts on the
ADVIA 120 hematology system for estimation of fetal lung
maturation. Clin Chim Acta 2004; 340:85-92. |
| |
| Kaplan LA, Chapman JF, Bock JL, Santa Maria E, Clejan
S, Huddleston DJ, Reed RG and Bernstein LH: Prediction
of Respiratory Distress Syndrome Using the Abbott FLM II
Amniotic Fluid assay. Clin Chim Acta 2002; 326:61-68. |
| |
| |
|
